Agilent Technologies Inc.

5301 Stevens Creek Blvd
CA 95051 Santa Clara
US

LinkedIn
Contact WebSite

Agilent Technologies Inc. is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide.

Article

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy
Sponsored • Whitepaper • Pharma

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Agilent to Buy Canadian CDMO Biovectra for $925 Million
News

Agilent to Buy Canadian CDMO Biovectra for $925 Million

Santa Clara, CA-based Agilent Technologies has signed a definitive agreement to acquire specialized contract development and manufacturing organization Biovectra from H.I.G. Capital in a move to expand its end-to-end biopharma solutions.

Empty Image
News

Agilent Technologies Reports First Quarter 2010 Results